Curis Inc (CRIS) stock
CRISNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3092% below fair value
$0.54+0.11 (+24.32%)
Close on Nov 17, 2026Market cap $1.13MP/E –Yield –
Curis pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Curis's pe ratio was 129.7× on Jan 31, 2013.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2013 | Jan 31, 2013 | 129.7× | −10.2 |
| 2012 | Dec 31, 2012 | 139.9× | – |
See a number that looks wrong?